Recombinant Human VEGFC Protein (Thr103-Arg227, Cys156Ser), C-10×His-tagged
Product Description
Cat
IMP-9889
Official Symbol
VEGFC
Product Overview
Recombinant human VEGF-C protein (Thr103-Arg227, Cys156Ser) with a C-terminal 10-His tagwas expressed in Mouse myeloma cell line.
Description
The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. The encoded protein promotes angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels. The proprotein is further cleaved into a fully processed form that can bind and activate VEGFR-2 and VEGFR-3 receptors.
Expression System
Mouse myeloma cell line
Species
Human
Tag
C-10×His
Predicted N Terminal
Thr103
Form
Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Molecular Mass
Predicted Molecular Mass: 15.4 kDa
SDS-PAGE: 22-24 kDa, reducing conditions
Protein length
Thr103-Arg227, Cys156Ser
Bio-activity
Measured in a cell proliferation assay using HMVEC human microvascular endothelial cells. The ED50 for this effect is 1-5 μg/mL. Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human VEGF R3/Flt-4 Fc Chimera at 5 μg/mL (100 μL/well) can bind Recombinant Human VEGF-C (Cys156Ser) with an apparent Kd <40 nM.
Endotoxin
<0.10 EU/μg of the protein by the LAL method.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
Reconstitution
Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Data Sheet MSDS
For research or industrial raw materials, not for personal medical use!

Online Inquiry
Contact Info